Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elke M G J de Jong

Showing results (1-10 of 119) with videos related to

Pageof 12
Sort By:
Nederlands Tijdschrift Voor Geneeskunde|March 15, 2013
[Is psoriasis a dependent cardiovascular risk factor?]Marlies Wakkee, Elke M G J de Jong
Archives of Dermatology|September 23, 2009
Psychological distress in patients with morphea and eosinophilic fasciitisElisabeth B M Kroft, Elke M G J de Jong, Andrea W M Evers
American Journal of Clinical Dermatology|April 10, 2009
Efficacy of topical tacrolimus 0.1% in active plaque morphea: randomized, double-blind, emollient-controlled pilot studyElisabeth B M Kroft, Tamara J Groeneveld, Marieke M B Seyger, et al.
The Journal of Dermatological Treatment|July 24, 2008
Cardiovascular risk factors in high-need psoriasis patients and its implications for biological therapiesRieke J B Driessen, Jan B Boezeman, Peter C M Van De Kerkhof, et al.
Skin Research and Technology : Official Journal of International Society for Bioengineering and the Skin (ISBS) [And] International Society for Digital Imaging of Skin (ISDIS) [And] International Society for Skin Imaging (ISSI)|June 24, 2020
Value of GPSkin for the measurement of skin barrier impairment and for monitoring of rosacea treatment in daily practiceJade G M Logger, Rieke J B Driessen, Elke M G J de Jong, et al.
Skin Research and Technology : Official Journal of International Society for Bioengineering and the Skin (ISBS) [And] International Society for Digital Imaging of Skin (ISDIS) [And] International Society for Skin Imaging (ISSI)|June 16, 2020
Evaluation of a simple image-based tool to quantify facial erythema in rosacea during treatmentJade G M Logger, Elke M G J de Jong, Rieke J B Driessen, et al.
Clinical and Experimental Dermatology|August 14, 2024
Revealing patient characteristics and treatment outcomes among ultra-long users of biologics for psoriasisNikki F T Henckens, Marisol E Otero, Juul M P A van den Reek, et al.
The Journal of Dermatological Treatment|May 7, 2009
Epidemiology and prescribed treatments in childhood psoriasis: a survey among medical professionalsMichelle E A De Jager, Peter C M Van de Kerkhof, Elke M G J De Jong, et al.
Journal of the American Academy of Dermatology|November 11, 2009
Efficacy and safety of treatments for childhood psoriasis: a systematic literature reviewMichelle E A de Jager, Elke M G J de Jong, Peter C M van de Kerkhof, et al.
American Journal of Clinical Dermatology|March 18, 2017
Morphea and Eosinophilic Fasciitis: An UpdateJorre S Mertens, Marieke M B Seyger, Rogier M Thurlings, et al.
Pageof 12

Showing results (1-10 of 119) with videos related to

Sort By:
Pageof 12
Nederlands Tijdschrift Voor Geneeskunde|March 15, 2013
[Is psoriasis a dependent cardiovascular risk factor?]Marlies Wakkee, Elke M G J de Jong
Archives of Dermatology|September 23, 2009
Psychological distress in patients with morphea and eosinophilic fasciitisElisabeth B M Kroft, Elke M G J de Jong, Andrea W M Evers
American Journal of Clinical Dermatology|April 10, 2009
Efficacy of topical tacrolimus 0.1% in active plaque morphea: randomized, double-blind, emollient-controlled pilot studyElisabeth B M Kroft, Tamara J Groeneveld, Marieke M B Seyger, et al.
The Journal of Dermatological Treatment|July 24, 2008
Cardiovascular risk factors in high-need psoriasis patients and its implications for biological therapiesRieke J B Driessen, Jan B Boezeman, Peter C M Van De Kerkhof, et al.
Skin Research and Technology : Official Journal of International Society for Bioengineering and the Skin (ISBS) [And] International Society for Digital Imaging of Skin (ISDIS) [And] International Society for Skin Imaging (ISSI)|June 24, 2020
Value of GPSkin for the measurement of skin barrier impairment and for monitoring of rosacea treatment in daily practiceJade G M Logger, Rieke J B Driessen, Elke M G J de Jong, et al.
Skin Research and Technology : Official Journal of International Society for Bioengineering and the Skin (ISBS) [And] International Society for Digital Imaging of Skin (ISDIS) [And] International Society for Skin Imaging (ISSI)|June 16, 2020
Evaluation of a simple image-based tool to quantify facial erythema in rosacea during treatmentJade G M Logger, Elke M G J de Jong, Rieke J B Driessen, et al.
Clinical and Experimental Dermatology|August 14, 2024
Revealing patient characteristics and treatment outcomes among ultra-long users of biologics for psoriasisNikki F T Henckens, Marisol E Otero, Juul M P A van den Reek, et al.
The Journal of Dermatological Treatment|May 7, 2009
Epidemiology and prescribed treatments in childhood psoriasis: a survey among medical professionalsMichelle E A De Jager, Peter C M Van de Kerkhof, Elke M G J De Jong, et al.
Journal of the American Academy of Dermatology|November 11, 2009
Efficacy and safety of treatments for childhood psoriasis: a systematic literature reviewMichelle E A de Jager, Elke M G J de Jong, Peter C M van de Kerkhof, et al.
American Journal of Clinical Dermatology|March 18, 2017
Morphea and Eosinophilic Fasciitis: An UpdateJorre S Mertens, Marieke M B Seyger, Rogier M Thurlings, et al.
Pageof 12